S&P 500   3,916.64
DOW   31,861.98
QQQ   304.73
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Modern Day Options Trading For Beginners! (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   304.73
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Modern Day Options Trading For Beginners! (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   304.73
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Modern Day Options Trading For Beginners! (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   304.73
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Modern Day Options Trading For Beginners! (Ad)pixel
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Modern Day Options Trading For Beginners! (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
NYSE:A

Agilent Technologies - A Stock Forecast, Price & News

$133.18
-3.64 (-2.66%)
(As of 03/17/2023 06:40 PM ET)
Add
Compare
Today's Range
$132.73
$136.92
50-Day Range
$133.18
$159.06
52-Week Range
$112.52
$160.26
Volume
2.05 million shs
Average Volume
1.37 million shs
Market Capitalization
$39.38 billion
P/E Ratio
30.06
Dividend Yield
0.68%
Price Target
$163.31

Agilent Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
22.6% Upside
$163.31 Price Target
Short Interest
Healthy
1.06% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.00
Upright™ Environmental Score
News Sentiment
0.04mentions of Agilent Technologies in the last 14 days
Based on 23 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.51%
From $5.68 to $6.22 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.02 out of 5 stars

Computer And Technology Sector

11th out of 608 stocks

Analytical Instruments Industry

1st out of 28 stocks


A stock logo

About Agilent Technologies (NYSE:A) Stock

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Agilent buys an Oregon State-founded biotech
Agilent Technologies Buys e-MSion
SVB Securities Sticks to Its Buy Rating for Agilent (A)
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Company Calendar

Ex-Dividend for 1/25 Dividend
12/30/2022
Dividend Payable
1/25/2023
Last Earnings
2/28/2023
Today
3/20/2023
Ex-Dividend for 4/26 Dividend
4/03/2023
Dividend Payable
4/26/2023
Next Earnings (Estimated)
5/23/2023
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$163.31
High Stock Price Forecast
$174.00
Low Stock Price Forecast
$140.00
Forecasted Upside/Downside
+22.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$1.25 billion
Pretax Margin
23.02%

Debt

Sales & Book Value

Annual Sales
$6.93 billion
Cash Flow
$6.19 per share
Book Value
$18.97 per share

Miscellaneous

Free Float
N/A
Market Cap
$39.38 billion
Optionable
Optionable
Beta
1.04

Social Links


Key Executives

  • Michael R. McMullenMichael R. McMullen
    President, Chief Executive Officer & Director
  • Robert W. McMahon
    Chief Financial Officer & Senior Vice President
  • Darlene J. S. Solomon
    Chief Technology Officer & Senior Vice President
  • Katharine Knobil
    Chief Medical Officer
  • Michael TangMichael Tang
    Secretary, Senior Vice President & General Counsel













A Stock - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2023?

10 brokers have issued 1-year price objectives for Agilent Technologies' stock. Their A share price forecasts range from $140.00 to $174.00. On average, they expect the company's share price to reach $163.31 in the next twelve months. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2023?

Agilent Technologies' stock was trading at $149.65 at the beginning of 2023. Since then, A shares have decreased by 11.0% and is now trading at $133.18.
View the best growth stocks for 2023 here
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 23rd 2023.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Tuesday, February, 28th. The medical research company reported $1.37 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.06. The medical research company earned $1.76 billion during the quarter, compared to analysts' expectations of $1.70 billion. Agilent Technologies had a net margin of 19.09% and a trailing twelve-month return on equity of 30.35%. The business's quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.21 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Wednesday, February 22nd. Investors of record on Tuesday, April 4th will be paid a dividend of $0.225 per share on Wednesday, April 26th. This represents a $0.90 annualized dividend and a yield of 0.68%. The ex-dividend date is Monday, April 3rd.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.66%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 20.32%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 14.47% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its board has initiated a share buyback program on Monday, January 9th 2023, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4.4% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its second quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of $1.24-$1.27 for the period, compared to the consensus EPS estimate of $1.27. The company issued revenue guidance of $1.66 billion-$1.68 billion, compared to the consensus revenue estimate of $1.65 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (3.14%), Price T Rowe Associates Inc. MD (2.60%), Geode Capital Management LLC (2.06%), Morgan Stanley (1.40%), Impax Asset Management Group plc (1.33%) and Cantillon Capital Management LLC (1.14%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $133.18.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $39.38 billion and generates $6.93 billion in revenue each year. The medical research company earns $1.25 billion in net income (profit) each year or $4.43 on an earnings per share basis.

How many employees does Agilent Technologies have?

The company employs 18,100 workers across the globe.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 3/20/2023 by MarketBeat.com Staff